The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.20
Bid: 82.40
Ask: 83.40
Change: -0.80 (-0.95%)
Spread: 1.00 (1.214%)
Open: 82.60
High: 84.20
Low: 82.60
Prev. Close: 84.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on P&H contract and current trading

13 Dec 2021 07:00

RNS Number : 3574V
Costain Group PLC
13 December 2021
 

 

Costain Group PLC

13 December 2021

 

 

Update on Peterborough & Huntingdon contract and current trading

 

Costain is providing an update on the adjudication process regarding the legacy Peterborough and Huntingdon contract dispute. In addition, we are providing an update to guidance and re-confirm that full year adjusted operating profit is expected to be in line with market expectations. Year end net cash, before any period end timing benefits, will now be ahead of market expectations at around £100m.

 

We have now received several adjudication decisions, the most recent and material of which was received on 10 December 2021. In this claim, the adjudicator found in our favour on principle in respect of three out of the four compensation events.

 

However, he has chosen not to determine the financial amounts in respect of these compensation events. We will pursue a financial settlement with National Grid in respect of these compensation events. As not all compensation events have been decided in our favour, we now expect there to be an overall cash outflow in respect of the contract.

 

Under the terms of the termination agreement with National Grid, there is an expected requirement to make a payment of £53.5m in January 2022, which now represents the maximum cash outflow under the contract. Given the recent adjudication decision, we have an entitlement to recover a proportion of this payment and will be discussing the timing and amount with National Grid. The payment, if made, will not affect our banking arrangements and we will continue to have a strong balance sheet that enables us to deliver our business plan. There will be an associated charge to the income statement for the current financial year reflecting such payment.

 

We are making good progress on our journey to transform the business, reduce risk and improve returns. This, combined with the considerable government investment in infrastructure, allows us to look forward with confidence.

 

Our next scheduled update will be the 2021 full year results, which are due to be announced on 9 March 2022.

 

 

Enquiries

 

Investors and analysts

Louise Bryant, Costain

 

 

+44 7813 210 809

Financial media

Tim Rowntree, MHP

Peter Hewer, MHP

 

+44 203 128 8771

Costain@mhpc.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The person responsible for this announcement on behalf of Costain is Louise Bryant, Group Director of Communications & Investor Relations.

 

Background to the Peterborough & Huntingdon contract

On 29 June 2020, we announced that a termination and settlement agreement had been reached with National Grid to cease work on the Peterborough & Huntingdon gas compressor project following a significant change in scope. The agreement included a legal process, through adjudications, to agree up to £80.0m of identified compensation events, recover costs to date and eliminate a potential liability to National Grid for completing the works.

 

To date, we have recorded a charge to the income statement of £49.3m reflecting the cash position at termination. As outlined at our interim results in August, under the terms of the agreement, the cumulative outcome for us of these adjudications ranged from an additional cash receipt of up to a maximum of £50.0m to a cash payment of up to a maximum of £57.3m.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANAAFLEFFFA
Date   Source Headline
19th Sep 201911:52 amRNSScrip Dividend Reference Price
12th Sep 201910:21 amRNSHolding(s) in Company
21st Aug 20197:00 amRNSHalf-year Report
16th Aug 201910:26 amRNSHolding(s) in Company
5th Aug 201911:36 amRNSHolding(s) in Company
29th Jul 20194:49 pmRNSHolding(s) in Company
25th Jul 20194:54 pmRNSHolding(s) in Company
24th Jul 20193:53 pmRNSHolding(s) in Company
12th Jul 201910:07 amRNSHolding(s) in Company
9th Jul 20197:00 amRNSCostain to deliver Gatwick station redevelopment
5th Jul 201911:56 amRNSHolding(s) in Company
3rd Jul 20193:37 pmRNSHolding(s) in Company
2nd Jul 20194:01 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSCapital Markets Event
1st Jul 201910:32 amRNSBlock listing six monthly return
28th Jun 20197:00 amRNSTrading Update
25th Jun 20197:00 amRNSUnited Utilities framework contract
31st May 201910:33 amRNSTotal Voting Rights and Capital
15th May 20197:00 amRNSDividend - Scrip Alternative
8th May 201910:31 amRNSGrant of nil cost options
7th May 20194:50 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
3rd May 201912:02 pmRNSDirector/PDMR Shareholding
2nd May 201912:38 pmRNSHolding(s) in Company
1st May 20198:59 amRNSTotal Voting Rights and Capital
18th Apr 201911:11 amRNSScrip Dividend Reference Price
10th Apr 201910:27 amRNSDirector/PDMR Shareholding
3rd Apr 20192:51 pmRNSDirector/PDMR Shareholding
3rd Apr 20198:57 amRNSLong Term Incentive Plan - Listing Application
29th Mar 20199:02 amRNSTotal Voting Rights and Capital
22nd Mar 201910:53 amRNSNotice of AGM
22nd Mar 20197:00 amRNSCostain appointed to deliver A19 improvements
20th Mar 20197:00 amRNSCostain selected as AMP7 delivery partner
6th Mar 20197:00 amRNSFinal Results
6th Mar 20197:00 amRNSCEO Succession
1st Mar 20199:55 amRNSTotal Voting Rights
26th Feb 20198:32 amRNSHolding(s) in Company
25th Feb 20192:18 pmRNSHolding(s) in Company
6th Feb 201911:56 amRNSHolding(s) in Company
15th Jan 201911:49 amRNSHolding(s) in Company
9th Jan 201911:54 amRNSHolding(s) in Company
3rd Jan 20197:00 amRNSYear End Trading Update
2nd Jan 20198:00 amRNSBlock listing Interim Review
2nd Jan 20198:00 amRNSTotal Voting Rights
19th Dec 20183:33 pmRNSHolding(s) in Company
30th Nov 20182:31 pmRNSTotal Voting Rights
30th Nov 20187:00 amRNSNotice of Analyst Event
7th Nov 20187:00 amRNSSix-year framework contract award
29th Oct 20187:00 amRNSBlock Listing Application
17th Oct 20187:00 amRNSA2/M2 connected corridor trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.